🇺🇸 FDA
Pipeline program

Reslizumab

HS-3025

Approved small_molecule active

Quick answer

Reslizumab for Asthma is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 5 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials